Get the latest tech news
67-year-old receives world-first lung cancer vaccine as human trials begin
This experimental cancer immunotherapy is designed for the treatment of non-small cell lung cancer (NSCLC).
“We are now entering this very exciting new era of mRNA-based immunotherapy clinical trials to investigate the treatment of lung cancer,” said Siow Ming Lee, consultant medical oncologist from University College London Hospitals (UCLH), who leads the national study. UCLH consultant medical oncologists Prof Siow-Ming Lee and Dr Sarah Benafif with trial participant Janusz Racz. In this way we hope that in time we are able to show that the treatment is effective against lung cancer whilst leaving other tissues untouched,” said UCLH consultant medical oncologist Dr Sarah Benafif.
Or read this on r/tech